These included echocardiography (to measure remaining ventricular (LV) remodelling, systolic and diastolic function), arteriography (to measure arterial stiffness using pulse wave velocity [PWV] and augmentation index [AI]), BP(36) and cardiovascular and placental biomarkers (high-sensitivity troponin T [hs-cTnT], N-terminal pro b-type natriuretic peptide [NTproBNP], PlGF and sFlt; see supplementary material)

These included echocardiography (to measure remaining ventricular (LV) remodelling, systolic and diastolic function), arteriography (to measure arterial stiffness using pulse wave velocity [PWV] and augmentation…